1. Home
  2. JVSA vs ME Comparison

JVSA vs ME Comparison

Compare JVSA & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVSA
  • ME
  • Stock Information
  • Founded
  • JVSA 2021
  • ME 2006
  • Country
  • JVSA Hong Kong
  • ME United States
  • Employees
  • JVSA N/A
  • ME N/A
  • Industry
  • JVSA
  • ME Precision Instruments
  • Sector
  • JVSA
  • ME Health Care
  • Exchange
  • JVSA NYSE
  • ME Nasdaq
  • Market Cap
  • JVSA 80.7M
  • ME 68.4M
  • IPO Year
  • JVSA 2024
  • ME N/A
  • Fundamental
  • Price
  • JVSA $10.68
  • ME $2.42
  • Analyst Decision
  • JVSA
  • ME Hold
  • Analyst Count
  • JVSA 0
  • ME 1
  • Target Price
  • JVSA N/A
  • ME $9.40
  • AVG Volume (30 Days)
  • JVSA 30.9K
  • ME 226.4K
  • Earning Date
  • JVSA 01-01-0001
  • ME 01-28-2025
  • Dividend Yield
  • JVSA N/A
  • ME N/A
  • EPS Growth
  • JVSA N/A
  • ME N/A
  • EPS
  • JVSA 0.24
  • ME N/A
  • Revenue
  • JVSA N/A
  • ME $208,775,000.00
  • Revenue This Year
  • JVSA N/A
  • ME $22.00
  • Revenue Next Year
  • JVSA N/A
  • ME $17.31
  • P/E Ratio
  • JVSA $43.81
  • ME N/A
  • Revenue Growth
  • JVSA N/A
  • ME N/A
  • 52 Week Low
  • JVSA $10.02
  • ME $2.42
  • 52 Week High
  • JVSA $10.68
  • ME $13.74
  • Technical
  • Relative Strength Index (RSI)
  • JVSA N/A
  • ME 32.49
  • Support Level
  • JVSA N/A
  • ME $2.42
  • Resistance Level
  • JVSA N/A
  • ME $2.96
  • Average True Range (ATR)
  • JVSA 0.00
  • ME 0.19
  • MACD
  • JVSA 0.00
  • ME 0.01
  • Stochastic Oscillator
  • JVSA 0.00
  • ME 0.00

About JVSA JVSPAC ACQUISITION CORP

JVSPAC Acquisition Corp is blank check company.

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Share on Social Networks: